(MedPage Today) — At World Sleep 2025, a discussion group examined the emerging role of GLP-1 receptor agonists in obstructive sleep apnea (OSA), particularly tirzepatide (Zepbound), which late last year became the first FDA-approved drug for…
Source link : https://www.medpagetoday.com/meetingcoverage/wscvideopearls/117691
Author :
Publish date : 2025-09-29 15:33:00
Copyright for syndicated content belongs to the linked Source.
